User menu

The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function.

Bibliographic reference Mourad, Michel ; Wallemacq, Pierre ; De Meyer, Martine ; Brandt, Dimitri ; Van Kerkhove, Valérie ; et. al. The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function.. In: Clinical chemistry and laboratory medicine : CCLM / FESCC, Vol. 44, no. 10, p. 1192-8 (2006)
Permanent URL http://hdl.handle.net/2078.1/10744
  1. Venkataramanan Raman, Swaminathan Arun, Prasad Tata, Jain Ashok, Zuckerman Sheila, Warty Vijay, McMichael John, Lever Jacqueline, Burckart Gilbert, Starzl Thomas, Clinical Pharmacokinetics of Tacrolimus : , 10.2165/00003088-199529060-00003
  2. Sattler, Drug Metab Dispos, 20, 450 (1992)
  3. Saeki, J Biol Chem, 506 (1993)
  4. Haufroid Vincent, Mourad Michel, Van Kerckhove Val??rie, Wawrzyniak Jeremie, De Meyer Martine, Eddour Djamila Chaib, Malaise Jacques, Lison Dominique, Squifflet Jean-Paul, Wallemacq Pierre, The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients : , 10.1097/00008571-200403000-00002
  5. Macphee Iain A. M., Fredericks Salim, Tai Tracy, Syrris Petros, Carter Nicholas D., Johnston Atholl, Goldberg Lawrence, Holt David W., Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and p-glycoprotein correlate with dose requirement : , 10.1097/00007890-200212150-00002
  6. Zheng HongXia, Webber Steven, Zeevi Adriana, Schuetz Erin, Zhang Jiong, Bowman Pamela, Boyle Gerard, Law Yuk, Miller Susan, Lamba Jatinder, Burckart Gilbert J., Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms, 10.1034/j.1600-6143.2003.00077.x
  7. Thervet Eric, Anglicheau Dany, King Barry, Schlageter Marie-H??l??ne, Cassinat Bruno, Beaune Philippe, Legendre Christophe, Daly Ann K., Impact of cytochrome P450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients12 : , 10.1097/01.tp.0000090753.99170.89
  8. Hesselink D, Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus, 10.1016/s0009-9236(03)00168-1
  9. MacPhee Iain A. M., Fredericks Salim, Tai Tracy, Syrris Petros, Carter Nicholas D., Johnston Atholl, Goldberg Lawrence, Holt David W., The Influence of Pharmacogenetics on the Time to Achieve Target Tacrolimus Concentrations after Kidney Transplantation, 10.1111/j.1600-6143.2004.00435.x
  10. Levey Andrew S., A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation, 10.7326/0003-4819-130-6-199903160-00002
  11. Wallemacq, Clin Chem, 43, 1989 (1997)
  12. Goto Maki, Masuda Satohiro, Kiuchi Tetsuya, Ogura Yasuhiro, Oike Fumitaka, Okuda Masahiro, Tanaka Koichi, Inui Ken-ichi, CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation : , 10.1097/01.fpc.0000114747.08559.49
  13. Goto, Pharmacogenetics, 1, 3435 (2002)
  14. Anglicheau D., Association of the Multidrug Resistance-1 Gene Single-Nucleotide Polymorphisms with the Tacrolimus Dose Requirements in Renal Transplant Recipients, 10.1097/01.asn.0000073901.94759.36
  15. Hoffmeyer S., Burk O., von Richter O., Arnold H. P., Brockmoller J., Johne A., Cascorbi I., Gerloff T., Roots I., Eichelbaum M., Brinkmann U., Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo, 10.1073/pnas.97.7.3473
  16. Tanabe, J Pharmacol Exp Ther, 1 (2001)
  17. Yamauchi Atsushi, Ieiri Ichiro, Kataoka Yasufumi, Tanabe Mizuho, Nishizaki Takashi, Oishi Ryozo, Higuchi Shun, Otsubo Kenji, Sugimachi Keizo, Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene : , 10.1097/00007890-200208270-00024
  18. MacPhee Iain A.M., Fredericks Salim, Mohamed Maha, Moreton Michelle, Carter Nicholas D., Johnston Atholl, Goldberg Lawrence, Holt David W., Tacrolimus Pharmacogenetics: The CYP3A5*1 Allele Predicts Low Dose-Normalized Tacrolimus Blood Concentrations in Whites and South Asians : , 10.1097/01.tp.0000151766.73249.12
  19. Moutabarrik, Transplantation, 54, 506 (2002)
  20. Hebert Mary F, Dowling Amy LS, Gierwatowski Cynthia, Lin Yvonne S, Edwards Karen L, Davis Connie L, Marsh Christopher L, Schuetz Erin G, Thummel Kenneth E, Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors : , 10.1097/00008571-200311000-00002
  21. Anglicheau Dany, Le Corre Delphine, Lechaton Sophie, Laurent-Puig Pierre, Kreis Henri, Beaune Philippe, Legendre Christophe, Thervet Eric, Consequences of Genetic Polymorphisms for Sirolimus Requirements After Renal Transplant in Patients on Primary Sirolimus Therapy, 10.1111/j.1600-6143.2005.00745.x